Dave Emory’s entire life­time of work is avail­able on a flash dri­ve that can be obtained HERE. The new dri­ve is a 32-giga­byte dri­ve that is cur­rent as of the pro­grams and arti­cles post­ed by the fall of 2019. The new dri­ve (avail­able for a tax-deductible con­tri­bu­tion of $65.00 or more.)

WFMU-FM is pod­cast­ing For The Record–You can sub­scribe to the pod­cast HERE.

You can sub­scribe to e‑mail alerts from Spitfirelist.com HERE.

You can sub­scribe to RSS feed from Spitfirelist.com HERE.

Please con­sid­er sup­port­ing THE WORK DAVE EMORY DOES.

COMMENT: This post is a pre­view of an upcom­ing show in the “Bio-Psy-Op Apoc­a­lypse Now” series. As Mr. Emory has stressed, the pre­sen­ta­tion of these pro­grams in con­cep­tu­al­ly sep­a­rate pack­ages is for pur­pos­es of cog­ni­tive grasp. The con­sum­mate­ly bril­liant, con­sum­mate­ly evil “bio-psy-op” is an exam­ple of six or sev­en dimen­sion­al chess. It oper­ates on a num­ber of dif­fer­ent, over­lap­ping lev­els simul­ta­ne­ous­ly.

Note that the Nazi takeover in Ser­pen­t’s Walk occurs after the coun­try is attacked with genet­i­cal­ly-engi­neered bio­log­i­cal war­fare weapons. Although the nature of the infec­tion is dif­fer­ent, the over­all par­a­digm is iden­ti­cal. “Pacov” might be under­stood in a con­tem­po­rary con­text as stand­ing for “Pan­dem­ic Coro­n­aVirus.”

In Ser­pen­t’s Walk–which we have dis­cussed for decades–the SS go under­ground (which they did), buy into the opin­ion-form­ing media (which they did) and, infil­trate the mil­i­tary (which they have done), and, after a ter­ror­ist attack by genet­i­cal­ly-engi­neered virus­es dec­i­mates large parts of the Unit­ed States, mar­tial law is declared and the Nazis take over. NB: we do not know if “cross-vec­tor­ing” is occur­ring with the Covid-19 virus, how­ev­er that is some­thing to be con­tem­plat­ed and researched.

From Ser­pen­t’s Walk: ” . . . . ‘Pacov con­sists of two sep­a­rate re-work­ings of two DNA chains of exist­ing virus­es. It’s a pig­gy-back weapon, a two-stage oper­a­tion. You send in the first stage. The vec­tors . . . agents of trans­mis­sion . . . for Pacov‑1 are exten­sive. It trav­els through the air, the water, or direct­ly from per­son-to-per­son and is high­ly con­ta­gious. It spreads for hun­dreds of miles, if con­di­tions are opti­mal.  Pacov‑1 pro­duces only a mild, flu-like infec­tion that dis­ap­pears with­in a day or two. Pub­lic health author­i­ties would over­look it, nev­er con­sid­er it a seri­ous epi­dem­ic, and even if they did they’d have to look care­ful­ly to iso­late it. Once a vic­tim is over the ‘flu,’ Pacov‑1 becomes dor­mant and almost unde­tectable. A month or two lat­er, you send in the sec­ond stage: Pacov‑2 is also a virus, just as con­ta­gious as the first, and just as harm­less by itself. It reacts with Pacov‑1 to pro­duce a pow­er­ful coag­u­lant. . . . you die with­in three min­utes. No warn­ing, no vac­cine, no cure. Those not exposed to both stages remain unharmed. . . . Pacov‑2 goes inert, like Pacov‑1 with­in a week or two. Then you get your victim’s coun­try, all his prop­er­ty, in undam­aged con­di­tion. . . . and a lot of corpses to bury.’ . . . .” 

We note that, although a “coag­u­lant” is not caus­ing the phe­nom­e­non, blood clots are indeed one of the many symp­toms of the Covid-19: ” . . . . Doc­tors in hot spots across the globe have begun to report an unex­pect­ed preva­lence of blood clot­ting among COVID cas­es, in what could pose a per­fect storm of poten­tial­ly fatal risk fac­tors. . . . . . . It’s grow­ing so com­mon with severe COVID cas­es, doc­tors are rec­og­niz­ing it as a new pat­tern of clot­ting called COVID-19-asso­ci­at­ed coag­u­lopa­thy, or CAC, which is notably asso­ci­at­ed with high inflam­ma­to­ry mark­ers in the blood, like D‑dimer and fib­rino­gen. . . . ‘In the begin­ning of the out­break, we start­ed only giv­ing them med­i­cine to pre­vent clots. We saw that it was­n’t enough,’ Dr. Cristi­na Abad, an anes­the­si­ol­o­gist at Hos­pi­tal Clínicos San Car­los in Madrid, told ABC News. ‘They start­ed hav­ing pul­monary embolisms, so we start­ed [full] anti­co­ag­u­la­tion on every­one.’ . . .”

1.  Ser­pen­t’s Walk by “Ran­dolph D. Calver­hall;” Copy­right 1991 [SC]; Nation­al Van­guard Books; 0–937944-05‑X; p. 89.

. . . . “Yes. Well. ‘Pacov’ stands for ‘Pan­dem­ic Com­mu­ni­ca­ble Virus,’ one of the ugli­er results of mil­i­tary exper­i­men­ta­tion with recom­bi­nant DNA. Do you know what that is?” . . .

. . . . “Very well, let me tell you in layman’s terms.” Mul­der extend­ed a hand to shush Wrench, who had start­ed to speak. “Pacov con­sists of two sep­a­rate re-work­ings of two DNA chains of exist­ing virus­es. It’s a pig­gy-back weapon, a two-stage oper­a­tion. You send in the first stage. The vec­tors . . . agents of trans­mis­sion . . . for Pacov‑1 are exten­sive. It trav­els through the air, the water, or direct­ly from per­son-to-per­son and is high­ly con­ta­gious. It spreads for hun­dreds of miles, if con­di­tions are opti­mal.  Pacov‑1 pro­duces only a mild, flu-like infec­tion that dis­ap­pears with­in a day or two. Pub­lic health author­i­ties would over­look it, nev­er con­sid­er it a seri­ous epi­dem­ic, and even if they did they’d have to look care­ful­ly to iso­late it. Once a vic­tim is over the ‘flu,’ Pacov‑1 becomes dor­mant and almost unde­tectable. A month or two lat­er, you send in the sec­ond stage: Pacov‑2 is also a virus, just as con­ta­gious as the first, and just as harm­less by itself. It reacts with Pacov‑1 to pro­duce a pow­er­ful coag­u­lant. . . . you die with­in three min­utes. No warn­ing, no vac­cine, no cure. Those not exposed to both stages remain unharmed. . . . Pacov‑2 goes inert, like Pacov‑1 with­in a week or two. Then you get your victim’s coun­try, all his prop­er­ty, in undam­aged con­di­tion. . . . and a lot of corpses to bury.” . . . .    

2. “Why Are So Many Covid-19 Patients Also See­ing Blood Clots?” by Sasha Pezenik and Dr. L. Ned­da Dast­malchi; Good Morn­ing Amer­i­ca; 4/20/2020.

As the COVID-19 pan­dem­ic rav­ages a world still grap­pling with vast uncer­tain­ty over the virus, a new and unnerv­ing pat­tern has emerged in some patients.

Though nov­el coro­n­avirus symp­toms thus far have pre­sent­ed chiefly with­in the res­pi­ra­to­ry sys­tem, the infec­tion is swift­ly show­ing to be an all-out, sys­tem-wide assault that reach­es far past the lungs. Doc­tors in hot spots across the globe have begun to report an unex­pect­ed preva­lence of blood clot­ting among COVID cas­es, in what could pose a per­fect storm of poten­tial­ly fatal risk fac­tors.

In New Orleans, a man in his 30s was admit­ted to the hos­pi­tal a week into treat­ment for the flu, severe­ly sick. Devel­op­ing short­ness of breath, chest pain and an abnor­mal­ly rapid heart rate — he was test­ed for coro­n­avirus — doc­tors real­ized those symp­toms also are typ­i­cal of a pul­monary embolism: a poten­tial­ly dead­ly blood clot that can move from the legs to the lungs and dam­age the heart.

The man’s blood work already showed heart dam­age, though he had no known under­ly­ing med­ical con­di­tions, no recent trav­el, no recent surg­eries. His chest scans, shown first to ABC News, revealed a mas­sive clot. Termed a “sad­dle embo­lus” because it hooks over branch­es of both pul­monary arter­ies, it was severe­ly stress­ing the right side of the heart, unable to push blood against the clot already in its strained state.

“Thank­ful­ly, we were able to find this and treat this ear­ly, oth­er­wise it prob­a­bly would have killed him,” Dr. Siyab Pan­hwar, a car­dio­vas­cu­lar con­sult for the patient, told ABC News. . . .

. . . It’s grow­ing so com­mon with severe COVID cas­es, doc­tors are rec­og­niz­ing it as a new pat­tern of clot­ting called COVID-19-asso­ci­at­ed coag­u­lopa­thy, or CAC, which is notably asso­ci­at­ed with high inflam­ma­to­ry mark­ers in the blood, like D‑dimer and fib­rino­gen. . . .

. . . . In Spain, among the hard­est-hit nations, clot­ting cas­es have become so preva­lent in nov­el coro­n­avirus patients that doc­tors have begun rou­tine­ly treat­ing indi­vid­u­als with ther­a­peu­tic dos­es of anti­co­ag­u­la­tion med­ica­tion.

“In the begin­ning of the out­break, we start­ed only giv­ing them med­i­cine to pre­vent clots. We saw that it was­n’t enough,” Dr. Cristi­na Abad, an anes­the­si­ol­o­gist at Hos­pi­tal Clínicos San Car­los in Madrid, told ABC News. “They start­ed hav­ing pul­monary embolisms, so we start­ed [full] anti­co­ag­u­la­tion on every­one.” . . .